Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) has participated in 50 clinical trials with 49 currently active.
Therapeutic areas: Lymphoma, Mycosis Fungoides, Mycosis Fungoides/Sezary Syndrome.
Sponsors: Memorial Sloan Kettering Cancer Center.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) has 50 clinical trials on record, with 49 currently active. Their work covers Lymphoma, Mycosis Fungoides, Mycosis Fungoides/Sezary Syndrome.
Yes — Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.